Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions

Neutralizing potency of COVID‐19 vaccines against the SARS‐CoV‐2 Omicron (B.1.1.529) variant

(2022) Giuseppe Lippi et al.   JOURNAL OF MEDICAL VIROLOGY

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

(2022) Lihong Liu et al.   NATURE

SARS-CoV-2 variants and ending the COVID-19 pandemic

(2021) Arnaud Fontanet et al.   LANCET

The current second wave and COVID-19 vaccination status in India

(2021) Chiranjib Chakraborty et al.   BRAIN BEHAVIOR AND IMMUNITY

SARS-CoV-2 variants, spike mutations and immune escape

(2021) William T. Harvey et al.   NATURE REVIEWS MICROBIOLOGY

Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re‐infectivity, immune escape and vaccines activity

(2021) Chiranjib Chakraborty et al.   REVIEWS IN MEDICAL VIROLOGY

Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants

(2021) Chiranjib Chakraborty et al.   mBio

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

(2021) Bo Meng et al.   Cell Reports

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection

(2021) Chiranjib Chakraborty et al.   Annals of Medicine and Surgery

D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity

(2021) Manojit Bhattacharya et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor

(2021) Cecylia S. Lupala et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants

(2021) Deepali Gupta et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance

(2021) Chiranjib Chakraborty et al.   CURRENT OPINION IN PHARMACOLOGY

Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021

(2021) Lin T. Brandal et al.   Eurosurveillance

Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021

(2021) Laura Espenhain et al.   Eurosurveillance

Increased risk of death in COVID-19 hospital admissions during the second wave as compared to the first epidemic wave: a prospective, single-centre cohort study in London, UK

(2021) Martina Cusinato et al.   INFECTION

Winter of Omicron—The Evolving COVID-19 Pandemic

(2021) Carlos del Rio et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies

(2021) Saathvik R. Kannan et al.   JOURNAL OF AUTOIMMUNITY

OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear

(2021) Vikram Thakur et al.   JOURNAL OF MEDICAL VIROLOGY

Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa

(2021) Lulan Wang et al.   JOURNAL OF MEDICAL VIROLOGY

Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein

(2021) Suresh Kumar et al.   JOURNAL OF MEDICAL VIROLOGY

Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective

(2021) Shailendra K. Saxena et al.   JOURNAL OF MEDICAL VIROLOGY

Detection of SARS‐CoV‐2 Omicron (B.1.1.529) variant has created panic among the people across the world: What should we do right now?

(2021) Md. Rabiul Islam et al.   JOURNAL OF MEDICAL VIROLOGY

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

(2021) Salim S Abdool Karim et al.   LANCET

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

(2021) Wanwisa Dejnirattisai et al.   LANCET

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

(2021) Yunlong Cao et al.   NATURE

Heavily mutated Omicron variant puts scientists on alert

(2021) Ewen Callaway   NATURE

VarEPS: an evaluation and prewarning system of known and virtual variations of SARS-CoV-2 genomes

(2021) Qinglan Sun et al.   NUCLEIC ACIDS RESEARCH

Omicron N501Y mutation among SARS-CoV-2 lineages: In silico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine

(2021) Bexultan Kazybay et al.   Travel Medicine and Infectious Disease

Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts – What is known so far?

(2021) Sujan Poudel et al.   Travel Medicine and Infectious Disease

Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern

(2021) Elisabeth Mahase   BMJ-British Medical Journal

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

(2021) Li Zhang et al.   Emerging Microbes & Infections

D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin?

(2021) Chiranjib Chakraborty et al.   Molecular Therapy-Nucleic Acids

Omicron SARS-CoV-2 variant: What we know and what we don’t

(2021) Valentine Marie Ferré et al.   Anaesthesia Critical Care & Pain Medicine

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021

(2021)   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load

(2021) Jorge Quarleri et al.   GeroScience

Preparation for the challenge of heavily mutated Omicron variant

(2021) Yuanlin Song et al.   Clinical and Translational Medicine

How do we share data in COVID-19 research? A systematic review of COVID-19 datasets in PubMed Central Articles

(2020) Xu Zuo et al.   BRIEFINGS IN BIOINFORMATICS

GISAID: Global initiative on sharing all influenza data – from vision to reality

(2017) Yuelong Shu et al.   Eurosurveillance